Bioaster
  • EN
  • FR
Icon HR HR
  • Logo Linkedin
  • Logo Twiiter
Menu
  • Welcome to BIOASTER
    • A new model of innovation risk sharing
    • Governance & management
    • Ecosystem
    • SAB
    • Beliefs, missions, values
    • CSR
    • Quality
  • Fields of application
    • Antimicrobials
    • Vaccines
    • Microbiome
    • Diagnostics & Companion Diagnostics
  • Offers
    • Microbial – Samples of interest
    • Mecanisms of action – Prophylactic Solutions
    • Mechanism of action – Host response, activity, profiling & efficacy of your antimicrobials
    • In vitro/in vivo models
    • Biomarkers
    • Technological developments
    • Data
  • Technologies
    • Preclinical Models & Imaging
    • Bioassays, Microsystems and Optical Engineering
    • OMICS
    • Microbiology and molecular engineering
    • Clinical Operations
    • Data Science, Data Management & Digital Solutions
  • News
    • Press releases
    • Events
  • A unique work experience
    • Join us
    • Our jobs
    • HR policy & projects
    • Working together
  • A project with BIOASTER
    • Scientific communications
      • Publications
      • Posters & application notes
      • Videos
    • Case studies
    • Technologies designed by BIOASTER
    • Grants & EU projects
    • Transparency portal
    • References
    • Your contacts
  • Icon home
  • Contact
  • A question ?

Category: Live

2016 IRT’s Forum will take place in Paris on october, more infos to come

Posted on 6 May 2016
2016 IRT’s Forum will take place in Paris on october, more infos to come

« Collaboration today is key both for knowledge and technology innovation issues » Nathalie Garçon @biovisionforum 2016

Posted on 6 May 2016
« Collaboration today is key both for knowledge and technology innovation issues » Nathalie Garçon @biovisionforum 2016

BIOASTER demonstrates Its know-how on generation, production and purification of nanoparticles.

Posted on 6 May 2016
Within recent years, the development of genetically engineered recombinant VLPs has accelerated the need for new, improved downstream processes. The technologic unit “Protein and expression system engineering” of Bioaster has...

BIOASTER announces Hepatitis B Collaboration with Janssen and the Cancer Center of Lyon (CRCL).

Posted on 4 November 2015
Objective of the collaboration: bring a predictive model for the development of novel therapies. Lyon on November, 4th, 2015 BIOASTER, and Cancer Center of Lyon (CRCL, France) represented by its...

Collaborative study for a rapid diagnostic test for Ebola Virus Disease by BIOASTER and FUJIFILM Corporation

Posted on 20 October 2015
Lyon, October 12th, 2015 – BIOASTER, Microbiology Technology Institute, announced that it has confirmed and started a collaboration for the study of an Ebola Virus Disease (EVD) rapid diagnostic system...

Governance evolution at BIOASTER, microbiology technology institute

Posted on 20 April 2015
Nathalie GARÇON Chief Scientific Officer and Pascale BOISSEL Chief Financial Officer have been respectively named chief executive officer and deputy chief executive officer. Lyon, April 20th, 2015: BIOASTER microbiology technology...

BIOASTER is increasing its bioinformatic capabilities by signing a strategic partnership with IN2P3 Computing Center (CNRS)

Posted on 5 February 2015
Mass data storage and subatomic physics and astrophysics computing power are now being made available to the field of health-related and infectious disease microbiology. Lyon and Villeurbanne, February 5, 2015...

Previous 1 … 14 15
Bioaster Live
27/082024
Meet us to the next events…
read more
01/062024
Meet us to the next events…
read more
+See all
Share this page
  • A question?
  • Fields of application
  • Offers
  • Technologies
  • A project with BIOASTER
Bioaster
  • Logo Linkedin
  • Logo Twiiter

BIOASTER, the first Institute for Technological Innovation in Microbiology.
To promote, accelerate and bring new added value to collaborative projects with public and private partners to better respond to global health issues.

BIOASTER – Headquarter
40 avenue Tony Garnier
69007 Lyon
France

Phone: +33 (0)4 69 84 26 00
Fax: +33(0)4 69 84 25 80

BIOASTER – Paris
Institut Pasteur, Building F. Jacob
28 rue du Docteur Roux
75015 Paris
France

Phone: +33 (0)4 69 84 26 00
Fax: +33 (0)1 40 61 38 88

BIOASTER is represented in Japan by:
Oriox Japan Ltd. 3-4-25, Shimomeguro,
Tokyo, Japan

Phone: +81 3 3792 5600
Email: info@orioxj.com

Download presentation here

BIOASTER is supported by the French government under the "Programme d'Investissements d'Avenir" with the reference ANR-10-AIRT-03.
L'Europe s'engage en région Auvergne-Rhône-Alpes avec FEDER FRANCE 2030

BIOASTER Copyright © 2025

  • Legal notice
  • Personnal Data Protection Policy
  • Transparency portal
By continuing browsing this website, you accept the use of cookies or other tracers for statistics of visits to optimize the functionality of the site, and or privacy policy. AcceptReject Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT